Playlist
President Serdar Berdimuhamedov has signed a Constitutional Law titled “On the Legal Foundations of the Peace and Trust Policy of Neutral Turkmenistan”, setting out the country’s core principles and objectives in peace-oriented foreign policy.
The law outlines 14 key principles, including:
-
neutrality,
-
equality,
-
respect for human rights and freedoms,
-
non-interference in the internal affairs of other countries,
-
rejection of force,
-
cooperation based on openness and mutual trust.
A prominent feature of the law is the promotion of the philosophy “Dialogue is the Guarantee of Peace”, which is positioned as the cornerstone of Turkmenistan’s international engagement.
Among the 15 main goals of the peace and trust policy are:
-
leveraging the nation’s permanent neutrality in global affairs,
-
fostering trust-based and transparent relations,
-
enhancing regional and global security.
The document emphasizes that human dignity is the highest value in both domestic and international policy.
The legal framework of the policy is based on:
-
the Constitution of Turkmenistan,
-
UN General Assembly resolutions on Turkmenistan’s neutrality (1995, 2015, 2025),
-
and other international legal instruments.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz